T-cell receptor-CD3 complex (CD3 complex) (CD3 complex)

The T-cell receptor-CD3 complex (CD3 complex) is a multimeric protein assembly essential for T-cell activation and signal transduction. It consists of four invariant chains—gamma, delta, epsilon, and zeta—that associate with the antigen-specific T-cell receptor (TCR). The CD3 subunits contain immunoreceptor tyrosine-based activation motifs (ITAMs) in their cytoplasmic domains, which are phosphorylated upon antigen binding to initiate downstream signaling cascades. In the context of allogeneic hematopoietic stem cell transplantation, the CD3 complex on donor T cells is a primary therapeutic target for preventing or treating graft-versus-host disease (GvHD), as these cells are responsible for attacking host tissues. Drugs targeting the CD3 complex, such as monoclonal antibodies and bispecific T-cell engagers (BiTEs), work by depleting T cells, inducing TCR internalization, or redirecting T-cell cytotoxicity toward specific targets like tumor cells. However, systemic T-cell activation by these agents can lead to severe side effects, most notably cytokine release syndrome (CRS) and neurotoxicity. Therapeutic strategies often involve fine-tuning the affinity for CD3 to balance efficacy with the risk of over-activation. Overall, the CD3 complex remains a cornerstone of modern immunotherapy, enabling both the suppression of unwanted immune responses and the redirection of T cells against cancer.

Other names

Cluster of differentiation 3 complexT3 complexTCR-CD3 complexCD3 antigen

Drugs targeting the CD3 complex act through T-cell depletion (e.g., via ADCC or apoptosis), TCR-CD3 complex modulation or internalization to induce immunosuppression, or T-cell redirection using bispecific antibodies that bridge T cells to target cells (e.g., tumor cells) to trigger localized cytotoxicity.